COMBINATION IRON DEPLETION THERAPY

被引:50
作者
TAETLE, R
HONEYSETT, JM
BERGERON, R
机构
[1] UNIV CALIF SAN DIEGO,CTR CANC,DIV HEMATOL ONCOL,SAN DIEGO,CA 92103
[2] UNIV CALIF SAN DIEGO,CTR CANC,DIV LAB MED,SAN DIEGO,CA 92103
[3] UNIV CALIF SAN DIEGO,CTR CANC,DEPT PATHOL,SAN DIEGO,CA 92103
[4] UNIV CALIF SAN DIEGO,CTR CANC,DEPT MED,SAN DIEGO,CA 92103
[5] UNIV CALIF SAN DIEGO,CTR CANC,CANC BIOL PROGRAM,SAN DIEGO,CA 92103
关键词
D O I
10.1093/jnci/81.16.1229
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1229 / 1235
页数:7
相关论文
共 47 条
[11]   EFFECTS OF DIFFERENT TRANSFERRIN FORMS ON TRANSFERRIN RECEPTOR EXPRESSION, IRON UPTAKE, AND CELLULAR PROLIFERATION OF HUMAN-LEUKEMIC HL60 CELLS - MECHANISMS RESPONSIBLE FOR THE SPECIFIC CYTOTOXICITY OF TRANSFERRIN-GALLIUM [J].
CHITAMBAR, CR ;
SELIGMAN, PA .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (06) :1538-1546
[12]  
CHITAMBAR CR, 1987, CANCER RES, V47, P3929
[13]  
CHITAMBAR CR, 1988, BLOOD, V72, P1930
[14]  
ERIKSSON S, 1984, J BIOL CHEM, V259, P1695
[15]   INVITRO CYTO-TOXICITY OF DEFEROXAMINE ON HUMAN MARROW HEMATOPOIETIC PROGENITORS [J].
ESTROV, Z ;
COHEN, A ;
GELFAND, EW ;
FREEDMAN, MH .
TOXICOLOGY IN VITRO, 1988, 2 (02) :131-134
[16]  
ESTROV Z, 1987, BLOOD, V69, P757
[17]  
FORSBECK K, 1987, EUR J HAEMATOL, V39, P318
[18]  
FOSTER BJ, 1986, CANCER TREAT REP, V70, P1311
[19]   SERIAL STUDIES OF AUDITORY NEUROTOXICITY IN PATIENTS RECEIVING DEFEROXAMINE THERAPY [J].
GALLANT, T ;
BOYDEN, MH ;
GALLANT, LA ;
CARLEY, H ;
FREEDMAN, MH .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (06) :1085-1090
[20]   TRANSFERRIN RECEPTORS IN HUMAN-TISSUES - THEIR DISTRIBUTION AND POSSIBLE CLINICAL RELEVANCE [J].
GATTER, KC ;
BROWN, G ;
TROWBRIDGE, IS ;
WOOLSTON, RE ;
MASON, DY .
JOURNAL OF CLINICAL PATHOLOGY, 1983, 36 (05) :539-545